Conducting HIV vaccine trials in the time of COVID: HVTN 705 and HVTN 135

Gray, G.E2024-12-022024-12-022021https://hdl.handle.net/11288/597908National Institute of Allergy and Infectious Diseases ( NIAID) HIV/AIDS Strategic Working Group Meeting.enHIVTime of Covid-19HIV vaccineConducting HIV vaccine trials in the time of COVID: HVTN 705 and HVTN 135Presentation